Literature DB >> 23052374

Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens.

H M Fritsche1, A Aziz, F Eder, W Otto, S Denzinger, W F Wieland, M May, F Hofstädter, A Hartmann, M Burger.   

Abstract

Incidental prostate cancer is often found in cystoprostatectomy specimens. The presence of a clinically significant tumour has an impact on follow-up strategies. In prostatectomy specimen for prostate cancer, whole-mount sections improve diagnostic accuracy. The present study compares detection of incidental prostate cancer in complete to routine processing. We included 295 consecutive patients who underwent radical cystoprostatectomy. Between 01/1995 and 12/2003 (period I), specimens of 129 patients were partially processed, whereas between 01/2004 and 03/2009 (period II), specimens of 166 patients were completely processed. Incidental prostate cancer was detected overall in 91 (30.8 %) patients. Prostate cancer was detected in 24 (18.6 %) patients in period 1 and in 67 (40.4 %) patients in period 2 (p < 0.001). Potentially clinically significant prostate cancer was detected in 12 (9.2 %) and 29 (17.5 %) patients, respectively (p = 0.044). Complete embedding and processing of cystoprostatectomy specimen yield significantly more potentially clinically relevant prostate cancers. The present data suggest that notably in younger men the specimens should be completely processed.

Entities:  

Mesh:

Year:  2012        PMID: 23052374     DOI: 10.1007/s00428-012-1328-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  33 in total

1.  Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer.

Authors:  F Abbas; D Hochberg; F Civantos; M Soloway
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

2.  Synchronous primary carcinomas of the bladder and prostate.

Authors:  Sheng-Hui Lee; Phei-Lang Chang; Shao-Ming Chen; Guang-Huan Sun; Chien-Lun Chen; Biing-Yir Shen; Ya-Shen Wu; Ke-Hung Tsui
Journal:  Asian J Androl       Date:  2006-05       Impact factor: 3.285

3.  EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.

Authors:  Axel Heidenreich; Joaquim Bellmunt; Michel Bolla; Steven Joniau; Malcolm Mason; Vsevolod Matveev; Nicolas Mottet; Hans-Peter Schmid; Theo van der Kwast; Thomas Wiegel; Filliberto Zattoni
Journal:  Eur Urol       Date:  2010-10-28       Impact factor: 20.096

4.  Unsuspected Prostate Carcinoma and Prostatic Intraepithelial Neoplasm in Taiwanese Patients Undergoing Cystoprostatectomy.

Authors: 
Journal:  Mol Urol       Date:  1999

5.  Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens.

Authors:  Mazen Abdelhady; Ashraf Abusamra; Stephen E Pautler; Joseph L Chin; Jonathan I Izawa
Journal:  BJU Int       Date:  2006-10-09       Impact factor: 5.588

Review 6.  Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long-term oncological, functional, and quality of life results.

Authors:  Udo Nagele; Aristotelis G Anastasiadis; Arnulf Stenzl; Markus Kuczyk
Journal:  World J Urol       Date:  2011-02-05       Impact factor: 4.226

7.  Prostatic intraepithelial neoplasia in prostate specimens: frequency, significance and relationship to the sampling of the specimen (a retrospective study of 121 cases).

Authors:  O Aydin; E F Coşar; S Varinli; R Buğdayci; Z Tansuğ
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

8.  Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant?

Authors:  Roberta Mazzucchelli; Francesca Barbisan; Marina Scarpelli; Antonio Lopez-Beltran; Theodorus H van der Kwast; Liang Cheng; Rodolfo Montironi
Journal:  Am J Clin Pathol       Date:  2009-02       Impact factor: 2.493

9.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

Authors:  J I Epstein; P C Walsh; M Carmichael; C B Brendler
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

10.  Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy.

Authors:  Joseph A Pettus; Hikmat Al-Ahmadie; Daniel A Barocas; Theresa M Koppie; Harry Herr; S Machele Donat; Guido Dalbagni; Victor E Reuter; Semra Olgac; Bernard H Bochner
Journal:  Eur Urol       Date:  2007-07-26       Impact factor: 20.096

View more
  3 in total

1.  Incidental prostate cancer prevalence at radical cystoprostatectomy--importance of the histopathological work-up.

Authors:  C Wetterauer; M Weibel; J R Gsponer; T Vlajnic; T Zellweger; S Bütikofer; G Müller; H Püschel; A Bachmann; T C Gasser; L Bubendorf; C A Rentsch
Journal:  Virchows Arch       Date:  2014-10-01       Impact factor: 4.064

Review 2.  Concomitant bladder cancer and prostate cancer: challenges and controversies.

Authors:  Antonio Lopez-Beltran; Liang Cheng; Francesco Montorsi; Maria Scarpelli; Maria R Raspollini; Rodolfo Montironi
Journal:  Nat Rev Urol       Date:  2017-08-16       Impact factor: 14.432

3.  Concomitant Gleason Score ≥ 7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomy.

Authors:  Christian Thomas; Alexander Giesswein; Michael Hainz; Raimund Stein; Peter Rubenwolf; Frederik C Roos; Andreas Neisius; Sebastian Nestler; Christian Hampel; Wolfgang Jäger; Christoph Wiesner; Joachim W Thüroff
Journal:  Int Urol Nephrol       Date:  2015-09-16       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.